OpGen, Inc. (OPGN): Price and Financial Metrics

OpGen, Inc. (OPGN): $0.49

0.00 (0.83%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

F

OPGN Price/Volume Stats

Current price $0.49 52-week high $3.84
Prev. close $0.48 52-week low $0.17
Day low $0.45 Volume 162,900
Day high $0.50 Avg. volume 198,275
50-day MA $0.42 Dividend yield N/A
200-day MA $0.48 Market Cap 4.86M

OPGN Stock Price Chart Interactive Chart >

OPGN Stock Summary

  • OPGN has a market capitalization of $4,155,612 -- more than approximately just 2.23% of US stocks.
  • The volatility of OPGEN INC's share price is greater than that of 92.75% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for OPGN comes in at -175.35% -- higher than that of just 2.53% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to OPGEN INC are EMKR, AGCO, TWOU, ACIW, and INPX.
  • Visit OPGN's SEC page to see the company's official filings. To visit the company's web site, go to www.opgen.com.

OPGN Valuation Summary

  • In comparison to the median Healthcare stock, OPGN's EV/EBIT ratio is 104.79% lower, now standing at -0.7.
  • Over the past 105 months, OPGN's price/earnings ratio has gone up 8.1.

Below are key valuation metrics over time for OPGN.

Stock Date P/S P/B P/E EV/EBIT
OPGN 2023-12-29 1.4 1.6 -0.2 -0.7
OPGN 2023-12-28 1.4 1.6 -0.2 -0.7
OPGN 2023-12-27 1.4 1.6 -0.2 -0.7
OPGN 2023-12-26 1.4 1.6 -0.2 -0.7
OPGN 2023-12-22 1.4 1.6 -0.2 -0.7
OPGN 2023-12-21 1.4 1.6 -0.2 -0.7

OPGN Growth Metrics

    Its 5 year price growth rate is now at -99.58%.
  • Its 4 year cash and equivalents growth rate is now at 586.67%.
  • Its 3 year revenue growth rate is now at 26.47%.
OPGN's revenue has moved up $132,971 over the prior 49 months.

The table below shows OPGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 3.311231 -20.24373 -40.72673
2022-06-30 4.10165 -20.62097 -32.67944
2022-03-31 3.94606 -21.55475 -33.92559
2021-12-31 4.306031 -21.47928 -41.97246
2021-09-30 4.232821 -24.62876 -35.10417
2021-06-30 4.050454 -26.723 -36.72306

OPGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OPGN has a Quality Grade of D, ranking ahead of 6.34% of graded US stocks.
  • OPGN's asset turnover comes in at 0.068 -- ranking 75th of 81 Healthcare stocks.
  • PMD, MGLN, and THC are the stocks whose asset turnover ratios are most correlated with OPGN.

The table below shows OPGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.068 0.109 -1.125
2021-03-31 0.082 0.075 -1.281
2020-12-31 0.105 0.087 -1.177
2020-09-30 0.122 0.118 -1.429
2020-06-30 0.158 0.329 -1.982
2020-03-31 0.272 0.457 -3.454

OPGN Price Target

For more insight on analysts targets of OPGN, see our OPGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.00 Average Broker Recommendation 1.5 (Moderate Buy)


OPGN Latest News Stream


Event/Time News Detail
Loading, please wait...

OPGN Latest Social Stream


Loading social stream, please wait...

View Full OPGN Social Stream

Latest OPGN News From Around the Web

Below are the latest news stories about OPGEN INC that investors may wish to consider to help them evaluate OPGN as an investment opportunity.

OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update

Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of 2022Implemented certain cash management initiatives, including restructuring U.S. operations by reducing headcount during the third quarter of 2023Signed preferred stock purchase agreement with a potential strategic investor in October 2023Entered into a warrant inducement agreement with an institutional investor in October 2023Subsidiaries Curetis G

Yahoo | November 14, 2023

Why Is OpGen (OPGN) Stock Up 540% Today?

OpGen stock is undergoing a massive rally on Thursday following as OPGN investors react to two pieces of news from the company!

William White on InvestorPlace | October 12, 2023

Why Is Phio Pharma (PHIO) Stock Down 35% Today?

Phio Pharma stock is pulling back on Thursday after shares of PHIO underwent a massive rally on Wednesday with a preclinical trial update.

William White on InvestorPlace | October 12, 2023

Why Is Secoo (SECO) Stock Up 703% Today?

Secoo stock is experiencing a massive rally on Thursday with heavy trading of SECO shares despite a lack of news from the company.

William White on InvestorPlace | October 12, 2023

Why Is Tempest Therapeutics (TPST) Stock Down 35% Today?

Tempest Therapeutics stock is taking a beating on Thursday as shares of TPST retreat from a massive rally yesterday on clinical trial news!

William White on InvestorPlace | October 12, 2023

Read More 'OPGN' Stories Here

OPGN Price Returns

1-mo 7.69%
3-mo 16.11%
6-mo 117.78%
1-year -68.39%
3-year -99.17%
5-year -99.88%
YTD 16.67%
2023 -85.11%
2022 -85.90%
2021 -50.98%
2020 80.53%
2019 -95.65%

Continue Researching OPGN

Want to see what other sources are saying about Opgen Inc's financials and stock price? Try the links below:

Opgen Inc (OPGN) Stock Price | Nasdaq
Opgen Inc (OPGN) Stock Quote, History and News - Yahoo Finance
Opgen Inc (OPGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!